- Research article
- Open Access
In Helicobacter pylori auto-inducer-2, but not LuxS/MccAB catalysed reverse transsulphuration, regulates motility through modulation of flagellar gene transcription
BMC Microbiology volume 10, Article number: 210 (2010)
LuxS may function as a metabolic enzyme or as the synthase of a quorum sensing signalling molecule, auto-inducer-2 (AI-2); hence, the mechanism underlying phenotypic changes upon luxS inactivation is not always clear. In Helicobacter pylori, we have recently shown that, rather than functioning in recycling methionine as in most bacteria, LuxS (along with newly-characterised MccA and MccB), synthesises cysteine via reverse transsulphuration. In this study, we investigated whether and how LuxS controls motility of H. pylori, specifically if it has its effects via luxS-required cysteine metabolism or via AI-2 synthesis only.
We report that disruption of luxS renders H. pylori non-motile in soft agar and by microscopy, whereas disruption of mccAHp or mccBHp (other genes in the cysteine provision pathway) does not, implying that the lost phenotype is not due to disrupted cysteine provision. The motility defect of the ΔluxSHp mutant was complemented genetically by luxSHp and also by addition of in vitro synthesised AI-2 or 4, 5-dihydroxy-2, 3-pentanedione (DPD, the precursor of AI-2). In contrast, exogenously added cysteine could not restore motility to the ΔluxSHp mutant, confirming that AI-2 synthesis, but not the metabolic effect of LuxS was important. Microscopy showed reduced number and length of flagella in the ΔluxSHp mutant. Immunoblotting identified decreased levels of FlaA and FlgE but not FlaB in the ΔluxSHp mutant, and RT-PCR showed that the expression of flaA, flgE, motA, motB, flhA and fliI but not flaB was reduced. Addition of DPD but not cysteine to the ΔluxSHp mutant restored flagellar gene transcription, and the number and length of flagella.
Our data show that as well as being a metabolic enzyme, H. pylori LuxS has an alternative role in regulation of motility by modulating flagellar transcripts and flagellar biosynthesis through production of the signalling molecule AI-2.
Many bacteria release extra-cellular signalling molecules (auto-inducers) to perform intercellular communication. It is generally assumed that auto-inducers are employed to regulate aspects of bacterial behaviour in response to cell population density (so-called quorum sensing). This includes changes in the expression of genes crucial for bacterial survival or virulence [1, 2]. Auto-inducer-2 (AI-2) production is widespread among bacterial species; its formation is catalysed by the enzyme LuxS . Many Gram-positive and Gram-negative bacterial species possess LuxS, and in some it has been shown to catalyse AI-2 production and to control quorum sensing (QS). Good examples include Vibrio harveyi and Vibrio cholera, where AI-2 has been shown to regulate density-dependent bioluminescence and virulence factor production, respectively [4, 5]. luxS inactivation has also been shown to cause phenotypic alterations such as biofilm formation, changes in motility, toxin production, and reduced colonisation in various experimental infection models [3, 6].
In addition to its QS role, LuxS catalyses one of the steps of the activated methyl cycle (AMC). The AMC is a central metabolic pathway that generates the S-adenosylmethionine (S AM) required by methyltransferases allowing the widespread methylation of proteins and DNA needed for cell function. It recycles the toxic product of these reactions, S-adenosylhomocysteine (S AH), to help provide the cell with sulphur-containing amino acids . As part of the AMC, the Pfs enzyme, 5'-methylthioadenosine nucleosidase/S-adenosylhomocysteine nucleosidase converts S AH to S-ribosylhomocysteine (S RH) which is subsequently converted to homocysteine by LuxS. The precursor of AI-2, 4, 5-dihydroxy-2, 3-pentanedione (DPD) is generated as a by-product of this reaction. Through a process of dehydration and spontaneous cyclisation, some or all of the DPD is rearranged into a cocktail of chemically related molecules known as AI-2, including 4-hydroxy-5-methyl-3 (2H) furanone, (2R, 4S) -2-methyl-2, 3, 3, 4-tetrahydroxy-tetrahydrofuran and furanosyl borate diester. These have been shown to function as signals of communication between bacteria [3, 8, 9]. In some organisms, the AMC is different. For example, in Pseudomonas aeruginosa, LuxS and Pfs are replaced by a single enzyme (S AH hydrolase) which converts S AH to homocysteine in a one step reaction without the concomitant production of DPD .
Helicobacter pylori, a Gram-negative bacterium which causes peptic ulceration, gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma, contains a luxS homologue and produces AI-2 [10–12]. luxSHp (HP010526695; JHP0097J99) is positioned next to housekeeping genes mccAHp (HP010726695; JHP0099J99) and mccBHp (HP010626695; JHP0098J99) on the H. pylori chromosome, in a putative operon [13–15]. Data from our laboratory have demonstrated that the AMC of H. pylori is incomplete, and that LuxSHp, MccAHp and MccBHp constitute the sole cysteine biosynthetic pathway in this bacterium via a reverse transsulphuration pathway (RTSP) .
To date, the mechanisms underlying phenotypic changes exhibited as a result of luxSHp inactivation remain elusive. Two ΔluxSHp mutants have been shown to form biofilms more efficiently than the parent strain, indicating a possible but counterintuitive role of luxSHp in biofilm reduction . A subsequent study demonstrated that ΔluxSHp mutants in two strains lost growth-phase-dependent regulation of the gene encoding the major flagellin FlaA, and that cell culture supernatant containing AI-2 could increase flaA transcription . Studies by two independent groups looked at fitness of ΔluxSHp mutants in vivo using mouse and gerbil models, respectively [18, 19]. The motility of ΔluxSHp mutants was diminished and bacterial fitness reduced in co-infection experiments. Restoration of luxSHp by genetic complementation partially restored these phenotypes [18, 19]. The authors argued that the decreased fitness in the ΔluxSHp mutant was most likely due to the disruption of the cycle of S RH consumption and homocysteine synthesis and that AI-2 seemed unlikely to be a QS signal molecule . More recently however, Rader et al. reported that luxSHp disruption affected flagellar morphology in the absence of one of the transcriptional regulators (σ28, flgS or flgM), and that this could be complemented upon the addition of DPD. They reported that loss of luxSHp caused decreased transcription of the flagellar regulator flhA, and that expression of flhA was induced by DPD . This complementation through the addition of exogenous DPD resurrected the possibility of LuxS-dependent signalling in H. pylori.
There are several possible mechanisms whereby a motility defect could be associated with loss of luxSHp. Firstly, reduced flagellar structural gene transcription and related protein synthesis would lead to loss of flagella. Secondly, normal flagella structures may be synthesised in the ΔluxS mutant but lack of a functional motor may prevent rotation. Thirdly, both motor and flagellum may be functional, but unable to respond to tactic signals, leading to aimless movement.
In this study, we set out to distinguish between the mechanisms underlying the alteration in motility of ΔluxSHp mutants, and to clarify whether this originated from a disruption of metabolism or QS. To do this, electron microscopy was employed to examine flagellar assembly and the levels of individual components of flagella were assessed at a transcriptional and translational level. Our demonstration here of the lack of motility defects in mutants disrupted in components of the RTSP other than LuxS, coupled to the inability of cysteine to complement the motility defect of the ΔluxSHp mutant, shows that disruption of cysteine biosynthesis is not the mechanism underlying the reduction in motility. In contrast, we show that exogenously added AI-2 (or DPD) influences motility via regulating flagellar gene transcription (and thus the number and length of flagella). This supports the existence of an additional role for LuxS in H. pylori as a signalling molecule synthase.
Strains and growth culture conditions
All strains used in this study are listed in Table 1. DH5α was used in the production of proteins needed for AI-2 biosynthesis and cloning . V. harveyi BB170 was used in the bioluminescence bioassay as a reporter strain . E. coli strains were routinely grown in Luria-Bertani (LB) (Bacto) broth or on agar plates at 37°C. V. harveyi was grown in LB or AB medium  at 30°C, also under normal atmospheric conditions. H. pylori strains were routinely grown and maintained on Columbia blood agar plates (No.2, with 5% [v/v] horse blood; Oxoid) or grown in Brucella broth (BB) (Bacto) containing 7% (v/v) fetal bovine serum (Gibco). H. pylori J99 was incubated at 37 °C for 24 h to 72 h as required in a MG500 VAIN-cabinet (Don Whitley Scientific) in an atmosphere of 5% CO2, 86% N2, and 6% O2 (all v/v). For motility experiments the method of Wand et al. was used to achieve motile cultures for analysis, see below. Antibiotics were used at the following concentrations: ampicillin at 100 μg/ml, kanamycin at 30 μg/ml.
Molecular biology methods
Preparation of plasmid DNA, DNA ligation, gel electrophoresis and transformation of E. coli strains were performed in accordance with standard methods . All PCRs were performed with Taq DNA polymerase (Roche Diagnostics, Lewes, UK). TA cloning was carried out using the pGEM-T vector system (Promega, Madison, WI). Plasmid DNA was extracted using the QIAquick spin miniprep kit (QIAGEN, UK). DNA fragments were purified from agarose gel using a QIAquick gel extraction kit (QIAquick, UK) according to the manufacturer's instruction. H. pylori genomic DNA was isolated as described previously . DNA sequencing was conducted using standard fluorescent dye terminator chemistries, and analysis performed using the Applied Biosystems 3730 DNA Analyzer system (Geneservice, Cambridge, UK, Applied Biosystems Inc, Foster City, CA.). Results were analysed using the Bioedit software suite .
Construction of the complemented ΔluxS+ strain
H. pylori J99 wild-type was transformed with the plasmid pGEMTluxSXN396 containing a km-sacB construct encoding kanamycin resistance (Kmr) and (5%) sucrose sensitivity (Sucs) . Disruption of the chromosomal luxS gene was accomplished by natural transformation, allelic exchange, and screening for kanamycin-resistance as previously described , resulting in the J99 ΔluxS mutant strain. The presence of the km-sacB cassette was verified by amplifying fragments of H. pylori chromosomal DNA using primers luxS-F/luxS-R (forward, 5'>GTG GCT TTA GCG GGA TGT TTT<3'; reverse, 5'>GCGA ACA AAT CCC CGC TG<3') and DNA sequencing. The J99 ΔluxS was then transformed with plasmid pGEMTluxS (encoding wild-type luxS), and transformants in which km-sacB had been replaced with the introduced original luxS locus were selected for sucrose resistance on medium containing 5% sucrose and screened for kanamycin sensitivity. The presence of the original luxS gene was verified by amplifying fragments on H. pylori chromosomal DNA using primers luxS-F/luxS-R and DNA sequencing.
Bacterial growth curves and V. harveyi bioluminescence assay
Bacterial broth cultures were started from a blood agar plate culture, diluted to an OD600 nm of 0.05 in fresh BB medium, and grown at 37°C in a VAIN-cabinet with shaking. OD600 nm measurements were taken at the 6 h, 24 h, 48 h and 72 h time points, and at the same time cell suspensions were harvested and filtered through a 0.2 μm pore size filter. The AI-2 activity in cell free supernatants (CFS) was tested as previously described using the V. harveyi reporter strain BB170 [9, 22]. Briefly, an overnight V. harveyi culture was diluted 1:2500 in fresh AB medium . CFS samples were diluted 1:10 in the AB medium containing BB170 into the 96 well bioluminescence plates to give a final volume of 200 μl and were incubated at 30°C. The bioluminescence and optical density were determined at 30 min intervals for at least 8 h using a luminometer (Anthos Labtech LUCY 1.0). AI-2 activity alterations in bioluminescence were expressed as induction (n-fold) over the negative control.
Plate motility assay of H. pylori was performed in Brucella broth medium (BD Biosciences), supplemented with 7% (v/v) fetal bovine serum (Gibco), 0.35%-0.45% (w/v) agar (No.1, Oxoid) and the indicator, 40 μg/ml triphenyl tetrazolium chloride (Sigma, UK). Inclusion of this indicator made it easier to see the small recombinant colonies. Plates were seeded with 5 μl H. pylori liquid culture (forming a circle with 3 mm diameter) standardised to an OD600 nm of 1.0 and were incubated at 37°C for up to 7 days under the conditions described above. The motility halos were recorded using a digital camera and the area of each halo was measured using a GS-800 Calibrated Densitometer (Biorad).
Motility analysis was also carried out by direct observation under phase-contrast microscopy using a Nikon Eclipse E600 after cells were grown in co-culture conditions as used by Wand et al.. Briefly, co-cultures of H. pylori-human gastric adenocarcinoma (AGS) cells were prepared (described below). After 24 h, 10 μl culture was placed onto a microscope slide and covered with a coverslip and freely-motile H. pylori cells were analysed under the microscope.
Plate motility bioassay using chemically defined media (CDM)
The liquid chemically defined media were prepared as previously described [15, 28]. 60 ml of sterile chemically defined media were added to 40 ml of molten 1% Oxoid No. 1 agar base to make 0.4% semi-solid chemically defined agar. Cysteine supplemented plates (CSP) were made by adding cysteine to the molten agar, shortly before it set. The final concentration of cysteine was 1.0 mM, which was non-limiting for H. pylori growth. The centre of each plate was seeded with one-day incubated H. pylori cells and was incubated for 5 days under the conditions described above. The motility halos were recorded using a digital camera and the area of each halo was measured using a GS-800 Calibrated Densitometer (Biorad).
Motility assay with AI-2 complementation
AI-2 was synthesised enzymatically as described previously using purified proteins LuxS E. coli and Pfs E. coli . For complementation of the ΔluxSHp motility phenotype, soft motility agar plates (0.4% w/v) were made as previously described. Bioluminescence activity of the AI-2 product was quantified using the V. harveyi bioassay and compared to CFS from H. pylori wild-type broth culture standardised to an OD600 nm of 1.0 at the time point in the growth curve that maximal AI-2 activity was measured. 1/400 diluted in vitro synthesised AI-2 product shows the same level of bioluminescence as seen in the H. pylori wild-type CFS in the V. harveyi bioassay. Therefore, in the complementation experiment AI-2 was added to motility plates to a final concentration of 0.25% (v/v). 24 h H. pylori cultures were seeded individually onto the centre of each motility plate and incubated for 5 days. The area of outward migration was recorded with a digital camera and measured using a GS-800 Calibrated Densitometer (Biorad).
Tissue culture and bacterial co-culture
All chemicals were obtained from Gibco, UK. AGS cells were grown in nutrient mixture Ham's F-12 supplemented with L-glutamine (200 mM) and fetal bovine serum (Gibco) (10% v/v) in a 37°C incubator containing 5% CO2. After cells had grown to confluency, a 1 in 5 or 1 in 8 dilution was added to a 75 cm2 flask containing fresh media mix and incubated in the same conditions as before to allow cells to re-grow to confluency.
AGS cells were counted using the trypan (0.35% v/v) blue dye method. Cells were seeded at a density of 1 × 105 cells/ml into 6 well plates and grown to 80% confluency. The cell-media mix was removed and replaced with 2 ml fresh F-12 media. Plates were inoculated with 24 h H. pylori liquid cultures standardised to an OD600 nm of 0.1 and incubated for one day in a microaerobic environment. Bacterial cells were then analysed using a phase-contrast Nikon Eclipse E600 microscope and electron microscopy.
Electron microscopy (EM)
H. pylori cells were pre-grown as described above for motility analysis. 15 μl of culture was allowed to settle on a carbon formvar grid (Agar Scientific) for 1 min. The suspension was removed and the grid washed by addition of 15 μl of Phosphate Buffered Saline (PBS) for an additional minute. This was removed and the cells stained with 0.5% Phospho-tungstic acid (PTA) pH 7.0 for 1 min. Grids were examined and pictures taken using a JEOL JEM1010 Transmission Electron Microscope. We quantified changes, rounding to the nearest 5% and quote means ± SD. Essentially, three groups of H. pylori cell samples prepared on different dates were examined. Each group of samples contained wild-type, ΔluxS and ΔluxS+ cells treated and not treated with DPD. For each group, 100 H. pylori cells from each culture sample were examined.
Cysteine and DPD complementation experiments
Cysteine from Sigma products was dissolved in distilled water according to the manufacturer's recommendation. Synthetic DPD was purchased from Omm Scientific Inc. DPD (AI-2) activity was quantified with the bioluminescence bioassay and compared to wild-type H. pylori grown to an OD600 nm of 1.0, at which maximal AI-2 activity was obtained. To test for complementation of motility, DPD (at a physiological concentration of 150 μM) and non-limiting cysteine (1.0 mM) were added individually to bacteria-AGS cell co-cultures. DPD was added after 10 h of incubation and once again after 18 h of incubation. Cysteine was added from the beginning of incubation. Bacterial motility and cells were observed and visualized by phase-contrast microscope and EM, respectively. For gene transcription studies, DPD (150 μM) and cysteine (1.0 mM) were also added (in the same way) individually to H. pylori liquid cultures of different genotypes. After 24 h, RNA was extracted and the transcript levels of genes of interest were measured.
Protein electrophoresis and western blotting
H. pylori wild-type, its ΔluxSHp mutant, the complemented ΔluxSHp+ mutant and controls (H. pylori wild-type 17874 , and derived mutants ΔflaA (a kind gift from Paul O'Toole) and ΔflgE) were grown in Brucella broth at 37°C for up to 24 h, at which point high levels of AI-2 activity were detected. To exclude global differences in protein production between strains, we corrected our loading for numbers of bacteria rather than for total protein levels. To do this, 24 h liquid (Brucella broth) culture of each strain was adjusted to OD600 nm of 1.0. A 500 μl cell sample of each strain was then centrifuged at 5500 rpm for 1 min. Culture supernatants were removed and cell pellets were fully resuspended in 1 ml sterile PBS. 100 μl protein sample was collected. The same volume of 2 × sample buffer was added and boiled for 10 min. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and subsequent immunoblotting were carried out as described previously under standard conditions . The gel contained 10% acrylamide. 4 μl protein stock from each strain sample was loaded into each well of the SDS-PAGE gel. For immunoblotting, proteins were transferred from SDS-PAGE gels to nitrocellulose paper by the methanol Tris-glycine system described by Towbin et al.. To see whether similar amounts of protein were loaded using our methodology, membranes were inspected following Ponceau red staining prior to immunoblotting; protein levels appeared similar on each membrane by inspection. The blots were incubated with rabbit polyclonal antibodies against H. pylori flagellin and hook protein (a generous gift from Paul O'Toole) . Bound antibodies were detected using secondary anti-rabbit IgG alkaline phosphatase conjugate antibody (Sigma, UK). The blots were developed using the BCIP/NBT substrate system (Dako, UK). The quantitative scan of the protein bands was performed using a GS-800 Calibrated Densitometer (Biorad). The reflective density (RD) of each protein band was measured using the Quantity One 4.6.5 software (Biorad).
RNA extraction and transcription analysis
RNA was isolated from H. pylori cells grown in BB medium for 24 h. Cultures were treated with RNA protection reagent (QIAGEN, UK) and RNA was extracted using RNeasy mini kit (QIAGEN, UK). Contaminating genomic DNA was removed using a DNA free kit (Ambion). Synthesis of cDNA was performed using Ominiscript RT kit (QIAGEN, UK) and random hexamers (Roche, Germany). Quantitation of transcripts of selected genes of interest was accomplished by quantitative reverse transcription-PCRs (qRT-PCRs) using Rotor-gene 3000. Primers utilised in RT-PCRs are listed in Table 2. All RT-PCR reaction mixtures contained 12.5 μl of SYBR Green Mix (QIAGEN, UK), 5 μl of gene specific primers, 2 μl cDNA template (cDNA was diluted 10-fold prior to adding into the RT-PCR reactions) and RNase free water to a final volume of 25 μl. The amplification program was 95°C for 15 min, followed by 35 cycles of 95°C for 15 sec, 56°C for 60 sec, and 72°C for 30 sec. All samples, including the controls (16 S rRNA and no-template), were run in triplicate. Transcript levels of each gene were normalised to the 16 S rRNA in each sample. The relative quantity of transcription of each gene was obtained using Pfaffl's analytical methodology.
Statistical analysis was by Student's t test.
The H. pylori ΔluxS mutant lost the ability to produce AI-2 while the wild-type, ΔmccAHp and ΔmccBHp mutants did not
Our previous study has demonstrated that luxSHp, mccAHp and mccBHp genes comprise a reverse transulphuration pathway in H. pylori, which is the sole cysteine biosynthesis pathway . We then wanted to determine whether these mutants in a motile strain of H. pylori, J99, would be useful in differentiating whether H. pylori motility was affected by luxS associated AI-2 production or by cysteine provision. Firstly, we needed to establish whether mutations in mccHp genes in our candidate motile strain J99 changed expression of luxSHp and AI-2 biosynthesis. To do this, H. pylori J99 wild-type and derived ΔmccAHp, ΔmccBHp, and ΔluxSHp mutants were grown in Brucella broth containing serum (10% v/v). Once they reached logarithmic growth phase, AI-2 activity in the culture supernatant was measured using the V. harveyi AI-2 bioassay previously described [4, 8]. As expected, the wild-type produced AI-2 in a growth dependent manner, with AI-2 accumulating during the late logarithmic phase, and reaching maximal levels in the stationary phase. During stationary phase, AI-2 levels decreased and were almost undetectable by 72 h. Similar data were obtained with ΔmccAHp and ΔmccBHp mutants, despite the fact that the ΔmccBHp mutant grew slightly less well than the other mutants and the wild-type. The ΔluxSHp mutant, unlike the wild-type and the other two mutants, yielded almost undetectable levels of bioluminescence at each time point, indicating that the production of AI-2 is luxSHp-dependent and that insertion of a kanamycin cassette (aphA3) into mccAHp and mccBHp did not affect expression of the downstream gene luxSHp (Figure. 1A).
Deletion of luxSHp abolishes motility while the ΔmccAHp and ΔmccBHp mutants remained motile
To investigate whether motility of H. pylori was affected by cysteine biosynthesis, we first compared the motility of H. pylori wild-type with ΔluxSHp, ΔmccAHp and ΔmccBHp mutants. To do this, a 24 h liquid culture of each strain was spotted onto each quarter of a semi-solid agar plate and incubated for up to 7 days. The resulting motility halo areas were quantified after 3, 5 and 7 days of incubation. Halo areas that surrounded the wild-type, ΔmccAHp and ΔmccBHp strains kept increasing during continuous incubation, although the ΔmccAHp strain was slightly delayed in comparison to the others. After 7 days of culture, the ΔluxSHp mutant remained almost non-motile and produced a significantly (p < 0.001) reduced motility halo compared to wild-type, ΔmccAHp and ΔmccBHp strains in 3 independent repeat experiments (Figure. 1B). After 7 days, the wild-type, ΔmccAHp and ΔmccBHp mutants produced halos of (mean ± SD) 8.5 ± 0.6 mm, n = 4; 5.6 ± 0.9 mm, n = 4; and 7.8 ± 0.6 mm, n = 4 increases in diameter, respectively, all significantly greater than the ΔluxSHp mutant which produced a halo size of 1.1 ± 0.1 mm, n = 4. These results revealed that the reduction in motility was likely a result peculiar to luxSHp mutation rather than due to disruption of cysteine biosynthesis.
Genetic complementation or exogenous AI-2 can restore the motility defect of the ΔluxSHp mutant, but exogenous cysteine addition cannot
To rule out the possibility that second site mutations in the ΔluxSHp mutant were inhibiting motility, genetic complementation was performed to create the ΔluxSHp+ strain (see Materials and Methods). The non-motile ΔflhB mutant was used as a negative control . 24 h cultures of wild-type, ΔluxSHp, ΔluxSHp+ and ΔflhBHp strains grown in Brucella broth were individually spotted onto normal motility plates. After 5 days of incubation, the mean halo diameter of the ΔluxSHp+ strain was 6.9 ± 0.2 mm, n = 4, which was slightly larger than that of the wild-type (4.7 ± 0.7 mm, n = 4). The ΔluxSHp and ΔflhBHp mutants showed non-motile phenotypes (Figure. 2A).
To examine whether AI-2 can influence the motility of H. pylori, we assessed the motility of the wild-type, ΔluxSHp and ΔflhB mutants on AI-2 supplemented plates (ASP). The ASP was prepared using 0.4% soft agar containing in vitro synthesised AI-2 (0.25% v/v). The buffer control plate (BCP) was also produced using 0.4% soft agar into which was added the buffer control solution (0.25% v/v) produced in parallel to in vitro AI-2 synthesis (buffer containing no AI-2). After 5 days of incubation, the halo size of the wild-type on ASP increased by 11.2 ± 0.7 mm, n = 4, compared with a 5.4 ± 0.2 mm, n = 4 increase on the non-supplemented plate (compare Figure. 2A or the right panel of Figure. 2B with the left panel of Figure. 2B). Whilst the ΔluxSHp mutant was non-motile on the BCP, the halo increased by 4.6 ± 0.4 mm, n = 4 on ASP (Figure 2B). The control strain ΔflhBHp mutant remained non-motile on the ASP (Figure. 2B).
Having established an influence on motility for one of the chemicals reliant on LuxSHp function (AI-2), we sought to establish whether another (cysteine) would have a similar influence. Our previous studies revealed that exogenous cysteine rescues growth defects of mutants unable to complete cysteine biosynthesis via the RTSP of H. pylori (ΔluxSHp, ΔmccAHp and ΔmccBHp mutants) in chemically defined broth . Chemical complementation of motility was thus performed using chemically defined plates supplemented with 1.0 mM cysteine. Methionine was added to these plates as the sulphur source since all known H. pylori strains are methionine auxotrophs. After 5 days of incubation, wild-type H. pylori and ΔmccAHp and ΔmccBHp mutants formed motility halos of 4.9 ± 0.3 mm, n = 4; 3.6 ± 0.6 mm, n = 4; and 4.3 ± 0.9 mm, n = 4 increases in diameter, respectively. The ΔluxSHp mutant remained non-motile (Figure. 2C).
Taken together, these data indicate that the motility defect of the ΔluxSHp mutant was restored either genetically or chemically with AI-2, but not with exogenous cysteine. This suggests that luxS and AI-2 play a role in enhancing bacterial motility, rather than an intact cysteine biosynthesis pathway, implying a likely role of luxSHp in signalling.
ΔLuxSHp mutants have altered flagella morphology and motility patterns
Motility plates effectively indicate motility phenotypes of the population, but do not give any indication of the structure of the motility organelles (flagella), or the motility pattern of individual cells. To characterise the phenotypes underlying the decreased ability of the ΔluxSHp mutant to swarm in soft agar, we examined motility of individual bacterial cells using phase-contrast microscopy and also the flagellar morphology of the cells using electron microscopy. Cells tested included wild-type, ΔluxSHp and ΔluxSHp+, all grown in the presence and absence of DPD and cysteine. All cells were grown in co-culture with human gastric adenocarcinoma (AGS) cells for 24 h before testing, as previous experiments in our laboratory have shown that this gives highly reproducible results in H. pylori motility experiments.
Phase-contrast microscopy revealed that > 40% of wild-type and ΔluxSHp+ cells were motile; whereas less than 2% of ΔluxSHp cells were motile. When grown with exogenous DPD, motile cells again made up > 40% of the population for wild-type and ΔluxSHp+ cells, but now also made up > 40% of the population for ΔluxSHp cells. Cultures of the ΔluxSHp grown with exogenous cysteine consistently contained less than 2% motile cells. To exclude the possibility that the restoration of motility of ΔluxSHp cells was due to an effect of DPD on AGS cells rather than on H. pylori, we set up a control sample in which the wild-type and ΔluxSHp mutant were co-cultured individually with AGS cells that had been treated with DPD overnight. DPD was washed off with the media before co-culturing. As expected, both wild-type and ΔluxSHp cells in these control cultures showed very similar motility phenotypes to those co-cultured with normal AGS cells, indicating that DPD is a functional signalling molecule to H. pylori cells rather than it working through affecting eukaryotic cells. Moreover, the approximate speed of motile ΔluxSHp cells was visibly lower compared to the wild-type, ΔluxS+ and all cell samples plus DPD.
Electron microscopic images (Figure. 3) showed that all samples tested (wild-type, ΔluxSHp and ΔluxSHp+, grown in the presence or absence of DPD) produced a flagellar filament of some kind in the majority of bacterial cells, but those of the ΔluxSHp strain were consistently short and usually fewer in number. In our experiments, nearly all of the wild-type cells tested had flagella (95% ± 3%, n = 3) and most of these had multiple flagella, which were usually at one pole and typically 3-4 in number (90% ± 3%, n = 3) (Figure. 3A). In contrast, fewer ΔluxSHp cells tested had flagella (70% ± 5%, n = 3) and these were typically shorter and also fewer in number (30% ± 5%, n = 3 of cells had only one or two short flagella (Figure. 3B)). The complemented ΔluxSHp+ cells were similar to wild-type, with nearly all cells possessing 3-4 normal long flagella at least one pole (95% ± 3%, n = 3) (Figure. 3C). Addition of DPD to ΔluxSHp cells also converted them to a wild-type morphology, with the vast majority producing 3-4 wild-type length flagella usually present at a single pole (95% ± 3%, n = 3) (Figure. 3E). Addition of DPD to wild-type cells had little significant effect with nearly all remaining flagellate as before (95% ± 3%, n = 3) although more cells were seen with a flagellum at both poles (Figure. 3D). Addition of DPD to the ΔluxSHp+ cells had a similar effect, with more cells with flagella at both poles (Figure. 3F).
Mutation of luxSHp resulted in the decreased production of flagellar proteins FlaA and FlgE
The reduced number and length of flagella in ΔluxSHp cells observed by electron microscopy could emanate from a number of different changes in the proteome. As previous work had suggested possible involvement of major flagella proteins, we investigated these first by immunoblotting whole cell lysates. Cell lysates were adjusted so that protein from equivalent numbers of bacteria was loaded (see Materials and Methods), and probed with anti-flagellin (FlaA and FlaB) and anti-FlgE (hook protein) antiserum (Figure. 4). In practice, FlaB levels were very similar between all wild-type and mutant strains and were not shown to vary in our subsequent transcription analysis. Our main aim here was to compare ratios of flagella proteins between wild-types and mutants, so we expressed results of other flagella proteins (FlaA and FlgE) relative to FlaB levels within each strain. H. pylori wild-type 17874, and derived mutants (ΔflaA and ΔflgE) were used as positive and negative controls, respectively. In our experiments, four repetitions were included, when the reflective density (RD) of each protein band was measured using Quantity One 4.6.5 software (Biorad).
We found that all strains tested produced FlaB at approximately the same level (Figure. 4). The reflective density of the FlaB bands of the wild-type, ΔluxSHp mutant and the complemented ΔluxSHp+ mutant were (means ± SD) 0.210 ± 2.0E-03 RD, n = 4; 0.204 ± 5.8E-04 RD, n = 4; and 0.207 ± 5.8E-04 RD, n = 4, respectively. We expressed all other results (FlaA and FlgE) relative to FlaB in each strain. Mutagenesis of LuxSHp reduced the expression of FlaA relative to FlaB (from mean 1.60 in the wild-type to 1.23 in the ΔluxSHp mutant, p < 0.01), and complementation increased the ratio back to wild-type levels (mean 1.70 in the ΔluxSHp+ mutant, p < 0.01 compared with the ΔluxSHp mutant). Next, we examined FlgE expression, and a similar trend was found (wild-type FlgE:FlaB ratio mean 0.74; ΔluxSHp mutant 0.51; complemented ΔluxSHp+ mutant 0.77; p < 0.01 for differences between ΔluxSHp mutant and wild-type and complemented stains). These data show that FlaA and FlgE synthesis was reduced relative to FlaB in the ΔluxSHp mutant and these changes were restored by genetic complementation.
AI-2 regulates the transcription of flagellar genes
Previous reports have provided evidence that luxSHp-dependent QS may occur to modulate motility via transcriptional regulation of flaA or flhA. We utilised quantitative RT-PCR (qRT-PCR) to screen for alterations in transcription of these and other genes involved in flagellar assembly to extend our understanding of the regulatory mechanisms that might be involved. To exclude an effect of cysteine biosynthesis, exogenous addition of cysteine was also undertaken. The concentration of cysteine was non-limiting to H. pylori growth. 16 S rRNA transcription was used for normalization and ureA served as a non-flagella linked gene control (Figure. 5D).
The flagellar genes tested included several from different regulatory hierarchy positions in flagellar synthesis : class 1 genes flhA (encodes flagellar regulator component), motA and motB (encode flagellar motor proteins); class 2 genes flaB (encodes hook-proximal minor flagellin) and flgE (enodes flagellar hook protein); and class 3 gene flaA (encodes major flagellin). fliI (encodes membrane-associated export ATPase of the flagellar basal body) was also examined (Figure. 5).
For class 1 genes tested, flhA showed a consistent pattern of 1.75 fold reduced transcription (p < 0.001), and both motA and motB showed a consistent pattern of 2 fold (p < 0.001) reduced transcription in the ΔluxSHp mutant compared to the wild-type (Figure. 5A). For class 2 genes tested, flgE was 1.5 fold (p < 0.001) down-regulated in the ΔluxSHp mutant; while flaB did not exhibit any significant change. flaA was the only class 3 gene tested, which was 3.5 fold (p < 0.001) down-regulated in the ΔluxSHp mutant compared to the wild-type (Figure. 5B). Additionally, the transcript of fliI was also significantly (1.5 fold, p < 0.001) decreased in the mutant (Figure. 5C).
The reduced transcription of flhA, motA, motB, flgE, flaA and fliI was restored genetically by the complementation of the mutant with the wild-type luxSHp gene. Also, 150 μM DPD was sufficient to restore the transcription of these genes in the ΔluxSHp mutant to levels similar to the wild-type (Figure. 5E). Although Figure 5E shows that 50 μM and 150 μM DPD induced almost the same level of bioluminescence as the wild-type, we chose to use 150 μM DPD in the complementation experiment because this concentration was shown to be more reproducible (it has the smaller error bar). In wild-type cells, addition of DPD markedly increased transcription of motA, motB, flaA and flaB, whilst flhA, flgE and fliI only showed a marginal increase. Exogenous addition of cysteine to the ΔluxSHp mutant did not significantly increase transcription of any of the genes studied; suggesting that addition of cysteine was not able to restore the transcription of flagellar genes (data not shown). Consistent with the analysis of protein levels, these RT-PCR data indicate that luxSHp disruption has a greater effect upon transcription of flaA than of flaB. Taken together, these data suggest that the effect of LuxS in cysteine metabolism does not regulate expression of flagellar genes, and that the effects on flagellar gene transcription are likely through AI-2 production.
The function of luxSHp is controversial due to putative roles both in signalling and metabolism. Disruption of cysteine biosynthesis by independent mutations that had no influence on AI-2 production did not alter motility. In contrast, the motility defect of a ΔluxSHp mutant of H. pylori was genetically complemented by luxSHp, or chemically complemented by the addition of exogenous AI-2 but not by exogenous cysteine. The processes underlying the loss of motility of the ΔluxSHp mutant were manifested by fewer and shorter flagella that presumably derived from the altered flagella protein production and the modulated expression of a number of genes linked with flagella assembly and function.
Previous studies have shown that mutations of luxSHp in H. pylori diminished motility on soft agar. The altered motility phenotype was restored completely by genetic complementation with luxSHp or significantly restored by metabolic complementation with wild-type CFS [18–20]. In contrast to our study, in Osaki et al. and Rader et al.'s studies complementation of luxSHp was performed by placing luxSHp at a second site in the chromosome rather than at the original locus [19, 20]. Like these previous reports, our study shows that abolished motility of J99 ΔluxSHp mutation was restored entirely by complementation with the luxSHp gene and significantly by in vitro synthesised AI-2. The previous studies, with complete complementation of motility with luxSHp through insertion at a new chromosomal locus, argue against polar effects of luxSHp mutagenesis on other genes which influence motility. Our study, with complementation with luxSHp through creating a revertant results in similar levels of LuxSHp to wild-type and thus better shows that the phenotypes attributed to the mutant were not due to secondary mutations elsewhere in the chromosome.
Furthermore, having demonstrated that MccAHp and MccBHp function consecutively to convert the product of LuxSHp (homocysteine) into cysteine as part of the RTSP , we reasoned that inactivation of any of these three enzymes would have a similar influence upon cysteine biosynthesis, whilst only the ΔluxSHp mutant would be devoid of AI-2. Thus, if the reduced motility of the ΔluxSHp mutant derived from disrupted cysteine biosynthesis, mutants in mccAHp and mccBHp would have a similar motility defect. Therefore, we performed an experiment to exclude the possibility that the effect on motility was due to non-specific secondary metabolic effects of LuxSHp. To do this, wild-type, ΔluxSHp, ΔmccAHp and ΔmccBHp strains were inoculated on the same motility plate, allowing the production of AI-2 and the biosynthesis of cysteine to be isolated from each other. As expected, only the ΔluxSHp mutant was non-motile. This, for the first time, suggests that motility of H. pylori cannot be affected by disrupting the cysteine provision pathway, but can be blocked by the loss of luxSHp itself. By using a chemically defined medium, we confirmed the provision of cysteine had no effect on motility of H. pylori.
Earlier publications have suggested that AI-2 may not act as a signal in some bacteria but instead may simply be a by-product of the important AMC pathway . In support of this, in some bacteria, production of AI-2 does appear to be associated with metabolic rather than regulatory phenomena . However, data from our motility bioassays using both motility plates and microscopy demonstrate that in H. pylori AI-2 (or DPD) controls motility. In our experiments, the shorter flagella observed in the mutant could result from the observed alteration in the FlaA:FlaB ratio as previously described [35, 36]. However, proving this would require extensive immuno-EM analysis with anti-FlaA and anti-FlaB antisera, which is beyond the scope of this work. As flaA has been confirmed to be essential for motility in H. pylori while flaB is a structural subunit of the flagellar filament which increases motility [35, 36], the change of the ratio between flagellins FlaA and FlaB may be one factor resulting in the abolished motility of the ΔluxSHp mutant. Also, LuxSHp/AI-2 appears to affect the position of flagella, suggesting that LuxSHp/AI-2 may affect genes involved in the formation of flagella at the cell poles.
The reduced expression of flagellar motor genes (motA and motB) which control flagellar rotation may be a further factor contributing to slower motility of the ΔluxSHp mutant although it could also be caused by the lower flagellar number requiring fewer motor units to encircle each flagellar base. Thus it is likely that the flagella in the ΔluxSHp strain are too short and too few to form effective flagellar propellers to produce Helicobacter movement. This is in contrast to a previous report where truncated flagella were only reported in G27 strains that also lacked one of the transcriptional regulators (σ28, flgS or flgM) and where wild-type length flagella were reported for the ΔluxSHp mutant alone . However, surprisingly in that report, the addition of DPD to the double mutants lengthened the flagellar filaments.
Mutants defective in flhA were previously described as being defective in flagellar apparatus assembly and in motility. Recently Rust and coworkers (2009) reported that the anti-sigma factor for σ28, FlgM, interacts with FlhA at the base of the Helicobacter flagellum and this interaction modulates the expression of flagellar genes by σ28. The decrease in flhA expression, seen in our ΔluxSHp mutant could explain the change in flagellar length but not via a FlgM-dependent pathway as seen by Rader et al., as Rust and coworkers report that FlgM levels were wild-type in a ΔflhA mutant in Helicobacter strains N6 and 88-3887 .
Both Rust and co-workers  and Neihus and co-workers  show that FlaB is not regulated by the same regulatory pathway as FlaA, and as FlaB levels in our ΔluxSHp mutant concur with this, the short flagella we observe in the ΔluxSHp mutant are likely to be predominantly composed of FlaB (normally hook-proximal) flagellins. These may be extended, to give functional length propellers by synthesis and assembly of FlaA in wild-type filaments and in filaments from luxSHp- complemented ΔluxSHp+ bacteria or ΔluxSHp bacteria+DPD which have longer flagella.
FlaB and FlgE are both part of the regulon that is controlled by the FlgS/FlgR two component system and the sigma factor σ54 (RpoN) . Interestingly, though no significant change in FlaB was found, FlgE production as well as its gene expression was affected by loss of LuxS/AI-2. This suggests that luxS inactivation might affect transcription of the same class of flagellar genes differently. One possibility is that the FlgR/FlgS-σ54 regulatory complex might have different effects on the same class of genes when affected by loss of LuxS; another possibility is that there may be additional regulation from the other regulator genes, for example flhF.
Flagellar assembly uses a secretion apparatus similar to type III secretion systems. This is dependent upon export chaperones that protect and transport structural subunits using the membrane-associated export ATPase, FliI [38, 39]. Therefore, the decreased transcription of fliI might be another factor in blocking motility via shortened filament length in the ΔluxSHp mutant as Helicobacter fliI mutants are non-motile and synthesise reduced amounts of flagellin (FlaA, FlaB) and hook protein (FlgE) subunits .
In our experiments, the motility defect, down-regulated flagellar gene expression and reduced synthesis of flagellar proteins in the ΔluxSHp mutant were due to loss of AI-2 only, and not to the metabolic effect of luxSHp on biosynthesis of cysteine. These results suggest that LuxS/AI-2 is likely to be a functional signalling system contributing to control motility in H. pylori. However, it is still uncertain whether AI-2 functions as a true QS signal in H. pylori, in part because there are no genes encoding proteins that can be confidently identified as components of an AI-2 sensory and regulatory apparatus in H. pylori[13, 40]. Also, we cannot exclude the possibility that AI-2 acts through other undefined effects and not as a signalling molecule, although as it is known to have similar effects through signalling in other bacteria, this appears unlikely.
Campylobacter jejuni also possesses a luxS homologue and produces AI-2. Inactivation of luxS in a C. jejuni strain (81-176) also resulted in reduced motility and affected transcription of some genes . However, despite its effect on signalling, AI-2 does not function as a QS molecule in C. jejuni (NCTC 11168) during exponential growth in vitro when a high level of AI-2 is produced . Thus, so far there is no good evidence to ascertain whether AI-2 functions as a true QS signal in this species. In H. pylori, Lee et al. and Osaki et al. looked at fitness of ΔluxSHp mutants in vivo using mouse and gerbil models, respectively [18, 19]. The authors did not favour a QS or even a signalling explanation for the reduced fitness mechanisms but both speculated that it might be caused by metabolic disturbances upon loss of luxSHp[18, 19]. However, it could potentially be explained by reduced signalling leading to reduced motility, and given the ecological niche of H. pylori there would be logic to a signalling (perhaps even QS) system increasing motility. For example, we speculate that if a microcolony of H. pylori in a particular area of the stomach reached a critical size it would be potentially advantageous for flagellar biogenesis to be enhanced so that highly motile bacteria could disseminate to new regions of the stomach. If this hypothesis was confirmed, it would have important implications for H. pylori virulence and for the spread of infection within and between people.
Our study suggests that as well as being a metabolic enzyme in the reverse transsulphuration pathway, H. pylori LuxS has a second role in regulation of motility by modulating flagellar transcripts and flagellar biosynthesis. This is achieved through production of the signalling molecule AI-2, rather than the metabolic effect of LuxS in cysteine biosynthesis.
activated methyl cycle
cell free supernatant
4, 5-dihydroxy-2, 3-pentanedione
reverse transsulphuration pathway.
Winzer K, Hardie KR, Williams P: Bacterial cell-to-cell communication: sorry, can't talk now - gone to lunch!. Curr Opin Microbiol. 2002, 5 (2): 216-222. 10.1016/S1369-5274(02)00304-1.
Camilli A, Bassler BL: Bacterial small-molecule signaling pathways. Science. 2006, 311 (5764): 1113-1116. 10.1126/science.1121357.
Vendeville A, Winzer K, Heurlier K, Tang CM, Hardie KR: Making 'sense' of metabolism: autoinducer-2, LuxS and pathogenic bacteria. Nat Rev Microbiol. 2005, 3 (5): 383-396. 10.1038/nrmicro1146.
Bassler BL, Greenberg EP, Stevens AM: Cross-species induction of luminescence in the quorum-sensing bacterium Vibrio harveyi. J Bacteriol. 1997, 179 (12): 4043-4045.
Camara M, Hardman A, Williams P, Milton D: Quorum sensing in Vibrio cholerae. Nat Genet. 2002, 32 (2): 217-218. 10.1038/ng1002-217.
Hardie KR, Heurlier K: Establishing bacterial communities by 'word of mouth': LuxS and autoinducer 2 in biofilm development. Nat Rev Microbiol. 2008, 6 (8): 635-643. 10.1038/nrmicro1916.
Duerre JA, Walker RD: The Biochemistry of Adenosylmethionine. 1977, Columbia University Press, New York
Winzer K, Hardie KR, Burgess N, Doherty N, Kirke D, Holden MT, Linforth R, Cornell KA, Taylor AJ, Hill PJ, Williams P: LuxS: its role in central metabolism and the in vitro synthesis of 4-hydroxy-5-methyl-3(2H)-furanone. Microbiology. 2002, 148 (Pt 4): 909-922.
Winzer K, Hardie KR, Williams P: LuxS and autoinducer-2: their contribution to quorum sensing and metabolism in bacteria. Adv Appl Microbiol. 2003, 53: 291-396. full_text.
Atherton JC: The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol. 2006, 1: 63-96. 10.1146/annurev.pathol.1.110304.100125.
Forsyth MH, Cover TL: Intercellular communication in Helicobacter pylori: luxS is essential for the production of an extracellular signaling molecule. Infect Immun. 2000, 68 (6): 3193-3199. 10.1128/IAI.68.6.3193-3199.2000.
Joyce EA, Bassler BL, Wright A: Evidence for a signaling system in Helicobacter pylori: detection of a luxS-encoded autoinducer. J Bacteriol. 2000, 182 (13): 3638-3643. 10.1128/JB.182.13.3638-3643.2000.
Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleischmann RD, Ketchum KA, Klenk HP, Gill S, Dougherty BA, Nelson K, Quackenbush J, Zhou L, Kirkness EF, Peterson S, Loftus B, Richardson D, Dodson R, Khalak HG, Glodek A, McKenney K, Fitzegerald LM, Lee N, Adams MD, Hickey EK, Berg DE, Gocayne JD, Utterback TR, Peterson JD, Kelley JM: The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature. 1997, 388 (6642): 539-547. 10.1038/41483.
Doig P, de Jonge BL, Alm RA, Brown ED, Uria-Nickelsen M, Noonan B, Mills SD, Tummino P, Carmel G, Guild BC, Moir DT, Vovis GF, Trust TJ: Helicobacter pylori physiology predicted from genomic comparison of two strains. Microbiol Mol Biol Rev. 1999, 63 (3): 675-707.
Doherty NC, Shen F, Halliday NM, Barrett DA, Hardie KR, Winzer K, Atherton JC: In Helicobacter pylori, LuxS is a key enzyme in cysteine provision through a reverse transsulfuration pathway. J Bacteriol. 2010, 192 (5): 1184-1192. 10.1128/JB.01372-09.
Cole SP, Harwood J, Lee R, She R, Guiney DG: Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol. 2004, 186 (10): 3124-3132. 10.1128/JB.186.10.3124-3132.2004.
Loh JT, Forsyth MH, Cover TL: Growth phase regulation of flaA expression in Helicobacter pylori is luxS dependent. Infect Immun. 2004, 72 (9): 5506-5510. 10.1128/IAI.72.9.5506-5510.2004.
Lee WK, Ogura K, Loh JT, Cover TL, Berg DE: Quantitative effect of luxS gene inactivation on the fitness of Helicobacter pylori. Appl Environ Microbiol. 2006, 72 (10): 6615-6622. 10.1128/AEM.01291-06.
Osaki T, Hanawa T, Manzoku T, Fukuda M, Kawakami H, Suzuki H, Yamaguchi H, Yan X, Taguchi H, Kurata S, Kamiya S: Mutation of luxS affects motility and infectivity of Helicobacter pylori in gastric mucosa of a Mongolian gerbil model. J Med Microbiol. 2006, 55 (Pt 11): 1477-1485. 10.1099/jmm.0.46660-0.
Rader BA, Campagna SR, Semmelhack MF, Bassler BL, Guillemin K: The quorum-sensing molecule autoinducer 2 regulates motility and flagellar morphogenesis in Helicobacter pylori. J Bacteriol. 2007, 189 (17): 6109-6117. 10.1128/JB.00246-07.
Yanisch-Perron C, Vieira J, Messing J: Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985, 33 (1): 103-119. 10.1016/0378-1119(85)90120-9.
DeKeersmaecker SC, Vanderleyden J: Constraints on detection of autoinducer-2 (AI-2) signalling molecules using Vibrio harveyi as a reporter. Microbiology. 2003, 149 (Pt 8): 1953-1956. 10.1099/mic.0.C0117-0.
Greenberg EP, Hastings JW, Ulitzer S: Induction of luciferase synthesis in Beneckea harveyi by other marine bacteria. Arch Microbiol. 1979, 120: 87-91. 10.1007/BF00409093.
Wand ME, Sockett RE, Evans KJ, Doherty N, Sharp PM, Hardie KR, Winzer K: Helicobacter pylori FlhB function: the FlhB C-terminal homologue HP1575 acts as a "spare part" to permit flagellar export when the HP0770 FlhBCC domain is deleted. J Bacteriol. 2006, 188 (21): 7531-7541. 10.1128/JB.00263-06.
Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. 1989, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N Y, 2
Letley DP, Rhead JL, Twells RJ, Dove B, Atherton JC: Determinants of non-toxicity in the gastric pathogen Helicobacter pylori. J Biol Chem. 2003, 278 (29): 26734-26741. 10.1074/jbc.M304071200.
Hall TA: BioEdit: a user-frendly biological sequence alignment editor and analysis program for Windows 95/98/NT//Nuclec Acids Symp. Ser. 1999, 41: 95-98.
Reynolds DJ, Penn CW: Characteristics of Helicobacter pylori growth in a defined medium and determination of its amino acid requirements. Microbiology. 1994, 140 (Pt 10): 2649-2656. 10.1099/00221287-140-10-2649.
Marshall BJ, Royce H, Annear DI, Goodwin CS, Pearman JW, Warren JR, Armstrong JA: Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Lett. 1984, 25: 83-88.
O'Toole PW, Kostrzynska M, Trust TJ: Non-motile mutants of Helicobacter pylori and Helicobacter mustelae defective in flagellar hook production. Mol Microbiol. 1994, 14 (4): 691-703. 10.1111/j.1365-2958.1994.tb01307.x.
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology. 1992, 24: 145-149.
Ryan KA, Karim N, Worku M, Penn CW, O'Toole PW: Helicobacter pylori flagellar hook-filament transition is controlled by a FliK functional homolog encoded by the gene HP0906. J Bacteriol. 2005, 187 (16): 5742-5750. 10.1128/JB.187.16.5742-5750.2005.
Niehus E, Gressmann H, Ye F, Schlapbach R, Dehio M, Dehio C, Stack A, Meyer TF, Suerbaum S, Josenhans C: Genome-wide analysis of transcriptional hierarchy and feedback regulation in the flagellar system of Helicobacter pylori. Mol Microbiol. 2004, 52 (4): 947-961. 10.1111/j.1365-2958.2004.04006.x.
Doherty N, Holden MT, Qazi SN, Williams P, Winzer K: Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing. J Bacteriol. 2006, 188 (8): 2885-2897. 10.1128/JB.188.8.2885-2897.2006.
Suerbaum S, Josenhans C, Labigne A: Cloning and genetic characterization of the Helicobacter pylori and Helicobacter mustelae flaB flagellin genes and construction of H. pylori flaA- and flaB-negative mutants by electroporation-mediated allelic exchange. J Bacteriol. 1993, 175 (11): 3278-3288.
Josenhans C, Labigne A, Suerbaum S: Comparative ultrastructural and functional studies of Helicobacter pylori and Helicobacter mustelae flagellin mutants: both flagellin subunits, FlaA and FlaB, are necessary for full motility in Helicobacter species. J Bacteriol. 1995, 177 (11): 3010-3020.
Rust M, Borchert S, Niehus E, Kuehne SA, Gripp E, Bajceta A, McMurry JL, Suerbaum S, Hughes KT, Josenhans C: The Helicobacter pylori anti-sigma factor FlgM is predominantly cytoplasmic and cooperates with the flagellar basal body protein FlhA. J Bacteriol. 2009, 191 (15): 4824-4834. 10.1128/JB.00018-09.
Jenks PJ, Foynes S, Ward SJ, Constantinidou C, Penn CW, Wren BW: A flagellar-specific ATPase (FliI) is necessary for flagellar export in Helicobacter pylori. FEMS Microbiol Lett. 1997, 152 (2): 205-211. 10.1111/j.1574-6968.1997.tb10429.x.
Lane MC, O'Toole PW, Moore SA: Molecular basis of the interaction between the flagellar export proteins FliI and FliH from Helicobacter pylori. J Biol Chem. 2006, 281 (1): 508-517. 10.1074/jbc.M507238200.
Rezzonico F, Duffy B: Lack of genomic evidence of AI-2 receptors suggests a non-quorum sensing role for luxS in most bacteria. BMC Microbiol. 2008, 8: 154-10.1186/1471-2180-8-154.
He Y, Frye JG, Strobaugh TP, Chen CY: Analysis of AI-2/LuxS-dependent transcription in Campylobacter jejuni strain 81-176. Foodborne Pathog Dis. 2008, 5 (4): 399-415. 10.1089/fpd.2008.0106.
Holmes K, Tavender TJ, Winzer K, Wells JM, Hardie KR: AI-2 does not function as a quorum sensing molecule in Campylobacter jejuni during exponential growth in vitro. BMC Microbiol. 2009, 9: 214-10.1186/1471-2180-9-214.
Surette MG, Bassler BL: Quorum sensing in Escherichia coli and Salmonella typhimurium. Proc Natl Acad Sci USA. 1998, 95 (12): 7046-7050. 10.1073/pnas.95.12.7046.
Alm RA, Ling LS, Moir DT, King BL, Brown ED, Doig PC, Smith DR, Noonan B, Guild BC, deJonge BL, Carmel G, Tummino PJ, Caruso A, Uria-Nickelsen M, Mills DM, Ives C, Gibson R, Merberg D, Mills SD, Jiang Q, Taylor DE, Vovis GF, Trust TJ: Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature. 1999, 397 (6715): 176-180. 10.1038/16495.
We thank Trevor Gray (QMC Histopathology EM Unit) for technical assistance with electron microscopy; Klaus Winzer (University of Nottingham) for kindly providing E. coli strains DH5α LuxS and DH5α Pfs; and Paul O'Toole (University College Cork, Ireland) for the generous gift of H. pylori 17874 strains and antibodies against H. pylori flagellin and hook protein.
This project was generously supported by the National Institute of Health Research through its funding of the Nottingham Digestive Diseases Centre Biomedical Research Unit. FS was supported by a studentship awarded by Overseas Research Students Awards Scheme (ORSAS) and Nottingham University. LH was supported by grant HFSP RGP57/2005 to RES. The support of the BBSRC to KH is also gratefully acknowledged.
JCA and KRH contributed to the design and supervision of the study. FS participated in the design of experiments, carried out the study, analysed data and drafted the manuscript. LH and RES contributed to the work of microscopy and flagellar morphology, and wrote the related section of the manuscript. ND contributed to the construction of the ΔluxS mutant. JTL and TLC designed and generated the plasmids needed for the construction of the complemented ΔluxS+ mutant. KRH, RES, TLC, LH and ND gave useful comments to the manuscript. JCA and FS coordinated the manuscript to the final version. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Shen, F., Hobley, L., Doherty, N. et al. In Helicobacter pylori auto-inducer-2, but not LuxS/MccAB catalysed reverse transsulphuration, regulates motility through modulation of flagellar gene transcription. BMC Microbiol 10, 210 (2010). https://doi.org/10.1186/1471-2180-10-210
- Quorum Sense
- Motility Defect
- Flagellar Gene
- Cysteine Biosynthesis
- Brucella Broth